ABSTRACT
Current evidence indicates that prolonged air travel predisposes to venous thrombosis and pulmonary embolism. An effect is seen once travel duration exceeds 6 to 9 hours and becomes obvious in long-haul passengers traveling for 12 or more hours. A recent records linkage study found that increase in thrombosis rate among arriving passengers peaked during the first week and was no longer apparent after 2 weeks. Medium- to long-distance travelers have a 2- to 4-fold increase in relative thrombosis risk compared with nontravelers, but the averaged absolute risk is small (approximately one symptomatic event per 2 million arrivals, with a case-fatality rate of approximately 2%) and there is no evidence that thrombosis is more likely in economy class than in business- or first-class passengers. It remains uncertain whether and to what extent thrombosis risk is increased by short-distance air travel or prolonged travel by motorcar, train, or other means. Most travelers who develop venous thrombosis or pulmonary embolism also have one or more other predisposing risk factors that may include older age, obesity, recent injury or surgery, previous thrombosis, venous insufficiency, malignancy, hormonal therapies, or pregnancy. Limited (though theoretically plausible) evidence suggests that factor V Leiden and the prothrombin gene mutation predispose to thrombosis in otherwise healthy travelers. Given that very many passengers with such predispositions do not develop thrombosis, and a lack of prospective studies to link predisposition with disease, it is not now possible to allocate absolute thrombosis risk among intending passengers or to estimate benefit-to-risk ratios or benefit-to-cost ratios for prophylaxis. Randomized comparisons using ultrasound imaging indicate a measurable incidence of subclinical leg vein thrombosis after prolonged air travel, which appears to increase with travel duration and is reduced by graded pressure elastic support stockings. Whether this surrogate outcome measure translates into clinical benefit remains unknown, but support stockings are likely to be more effective and have less adverse effects than the use of aspirin.
KEYWORDS
Travel thrombosis - risk factors - predisposition - prevention - stockings
REFERENCES
-
1
Homans J.
Thrombosis of the deep leg veins due to prolonged sitting.
N Engl J Med.
1954;
250
148-149
-
2
Kesteven P L.
Traveller's thrombosis.
Thorax.
2000;
55(suppl 1)
S32-S36
-
3
Paganin F, Laurent Y, Gaüzere B A, Blanc P h, Roblin X.
Pulmonary embolism on non-stop flights between France and Reunion Island.
Lancet.
1996;
347
1195-1196
-
4
Ribier G, Zizka V, Cysique J, Donatien J, Glaudon G, Ramialison C.
Venous thromboembolic complications following air travel. Retrospective study of 40 cases recorded in Martinique.
Rev Med Interne.
1997;
18
601-604
-
5
Eklof B, Kistner R L, Masuda E M, Sonntag B V, Wong H P.
Venous thromboembolism in association with prolonged air travel.
Dermatologic Surgery.
1996;
22
637-641
-
6
Sarvesvaran R.
Sudden natural deaths associated with commercial air travel.
Med Sci Law.
1986;
26
35-38
-
7
Clerel M, Caillard G.
Syndrome thrombo-embolique de la station assise prolongée et vols de longue durée: l'expérience du Service Médicale d'Urgence d'Aéroports De Paris.
Bull Acad Nat Med.
1999;
183
985-997
-
8
Lapostolle F, Surget V, Borroe S W et al..
Severe pulmonary embolism associated with air travel.
N Engl J Med.
2001;
345
779-783
-
9
Ferrari E, Chevallier T, Chapelier A, Baudouy M.
Travel as a risk factor for venous thromboembolic disease: a case-control study.
Chest.
1999;
115
440-444
-
10
Samama M M. the Sirius Study Group .
An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius Study.
Arch Intern Med.
2000;
160
3415-3420
-
11
Dimberg L A, Mundt K A, Sulsky S I, Liese B H.
Deep venous thrombosis associated with corporate air travel.
J Travel Med.
2001;
8
127-132
-
12
ten Wolde M, Kraaijenhagen R A, Schiereck J et al..
Travel and the risk of symptomatic venous thromboembolism.
Thromb Haemost.
2003;
89
499-503
-
13
Arya R, Barnes J A, Hossain U, Patel R K, Cohen A T.
Long-haul flights and deep vein thrombosis: a significant risk only when additional factors are also present.
Br J Haematol.
2002;
116
653-654
-
14
Kelman C W, Kortt M A, Becker N G et al..
Deep vein thrombosis and air travel: record linkage study.
BMJ.
2003;
327
1072-1076
-
15
Perez-Rodriguez E, Jimenez D, Diaz G et al..
Incidence of air travel-related pulmonary embolism at the Madrid-Barajas Airport.
Arch Intern Med.
2003;
163
2766-2770
-
16
Hughes R J, Hopkins R J, Hill S et al..
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study.
Lancet.
2003;
362
2039-2044
-
17
Schwarz T, Siegert G, Oettler W et al..
Venous thrombosis after long-haul flights.
Arch Intern Med.
2003;
163
2759-2764
-
18
Paganin F, Bourde A, Yvin J L et al..
Venous thromboembolism in passengers following a 12-h flight: a case-control study.
Aviat Space Environ Med.
2003;
74
1277-1280
-
19
Simpson K.
Shelter deaths from pulmonary embolism.
Lancet.
1940;
ii
744
-
20
Payling Wright H, Osborn S B.
Effect of posture on venous velocity, measured with 24NaCl.
Br Heart J.
1952;
14
325-330
-
21
Landgraf H, Vanselow B, Schulte-Huerman D, Mulman M V, Bergau L.
Economy class syndrome: rheology, fluid balance, and lower leg edema during a simulated 12-hour long distance flight.
Aviat Space Environ Med.
1994;
65
930-935
-
22
Bendz B, Rostrup M, Sevre K, Ondersen T O, Sandset P M.
Association between acute hypobaric hypoxia and activation of coagulation in human beings.
Lancet.
2000;
356
1657-1658
-
23
Hodkinson P D, Hunt B J, Parmar K, Ernsting J.
Is mild normobaric hypoxia a risk factor for venous thromboembolism?.
J Thromb Haemost.
2003;
1
2131-2133
-
24
Kesteven P L, Robinson B J.
Clinical risk factors for venous thrombosis associated with air travel.
Aviat Space Environ Med.
2001;
72
125-128
-
25
Arfvidsson B, Eklof B, Kistner R L, Masuda E M, Sato D.
Risk factors for venous thromboembolism following prolonged air travel: a “prospective” study.
Vasc Surg.
1999;
33
537-543
-
26
Dalen J E.
Economy class syndrome: too much flying or too much sitting?.
Arch Intern Med.
2003;
163
2674-2676
-
27
McQuillan A D, Eikelboom J W, Baker R I.
Venous thromboembolism in travellers: can we identify those at risk?.
Blood Coagul Fibrinolysis.
2003;
14
671-675
-
28
Martinelli I, Taioli E, Battaglioli T et al..
Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives.
Arch Intern Med.
2003;
163
2771-2774
-
29
Rege K P, Bevan D H, Chitolie A, Shannon M S.
Risk factors and thrombosis after airline flight.
Thromb Haemost.
1999;
81
995-996
-
30
Eekhoff E MW, Rosendaal F R, Vandenbroucke J P.
Minor events and the risk of deep venous thrombosis.
Thromb Haemost.
2000;
83
408-411
-
31
Belcaro G, Geroulakos G, Nicolaides A N, Myers K A, Winford M.
Venous thromboembolism from air travel. The LONFLIT study.
Angiology.
2001;
52
369-374
-
32
Jacobson B F, Munster M, Smith A et al..
The BEST study: a prospective study to compare business class versus economy class air travel as a cause of thrombosis.
S Afr Med J.
2003;
93
522-528
-
33
Scurr J H, Machin S J, Bailey-King S, Mackie I J, McDonald S, Coleridge Smith P D.
Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial.
Lancet.
2001;
357
1485-1489
-
34
Belcaro G, Cesarone M R, Shah S S et al..
Prevention of edema, flight microangiopathy and venous thrombosis in long flights with elastic stockings. A randomized trial: the LONFLIT 4 Concorde Edema-SSL Study.
Angiology.
2002;
53
635-645
-
35
Cesarone M R, Belcaro G, Errichi B M et al..
The LONFLIT4-Concorde deep venous thrombosis and edema study: prevention with travel stockings.
Angiology.
2003;
54
143-154
-
36
Cesarone M R, Belcaro G, Nicolaides A N et al..
The LONFLIT4-Concorde-Sigvaris Traveno Stockings in Long Flights (Eco TrS) Study: a randomized trial.
Angiology.
2003;
54
1-9
-
37
Cesarone M R, Belcaro G, Nicolaides A N et al..
Venous thrombosis from air travel: the LONFLIT3 study-prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial.
Angiology.
2002;
53
1-6
-
38
Cesarone M R, Belcaro G, Nicolaides A N et al..
Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLIT-FLITE randomized, controlled trial.
Angiology.
2003;
54
531-539
Alexander S GallusM.D.
Flinders Medical Center, Bedford Park 5042
Adelaide, South Australia, Australia
eMail: alexander.gallus@flinders.edu.au
